Home > Products > Featured products

ZINC77292789(Fmoc-Thr(galnac(Ac)3-alpha-D)-OH)

  Cat. No.:  DC60083   Featured
Chemical Structure
116783-35-8
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
Get Quotation Now
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
ZINC77292789 is a reagent for making synthetic MUC1 Glycopeptide Bearing βGalNAc-​Thr as a Tn Antigen Isomer Induces the Production of Antibodies against Tumor Cells. ZINC77292789 was a starting material to make trimeric MUC1 immunodominant motif antigen-​based anti-​cancer vaccine candidates.
Chemicals PropertiesBiological activity COA & MSDSRelated productsDatasheet
Cas No.: 116783-35-8
Chemical Name: Fmoc-Thr(galnac(Ac)3-alpha-D)-OH
Synonyms: Fmoc-Thr(galnac(Ac)3-alpha-D)-OH;N-Fmoc-O-beta-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine;N-Alpha-(9-Fluoroenyloxycarbonyl)-o-(2-Acetamido-2Deoxy-3,4,6-Tri-o-Acetyl-Alpha-d-Galactopyranosyl)-l-Threonine;N-Fmoc-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl]-L-threonine;(N-alpha-Fmoc-O-beta-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-alpha-D-galactopyranosyl)-L-threonine);Fmoc-Thr(Ac₃AcNH-α-Gal)-OH;Fmoc-Thr(GalNAc(Ac)?-α-D)-OH;Fmoc-Thr(GalNAc(Ac)3-a-D)-OH;N-FMOC-O-(2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-A-D-GALACTOPYRANOSYL)-L-THEREONINE;FMOC-THR(GALNAC(AC)3-α-D)-OH;Fmoc-Thr[GalNAc(Ac)3-α-D]-OH;Fmoc-O-β-(2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-α-D-galactopyranosyl)-L-threonine;GalNAc-Thr;GALNAC L-THREONINE;FMOC-L-THR(TNAC4)-OH;FMoc-Thr-(Ac3AcNH-α-Gal)-OH;FMOC-Thr(GalNAc(Ac)3-α-D)-OH;FMoc-Thr(α-D-GalNAc(Ac)3)-OH;FMOC-THR(AC3ACNH-ALPHA-GAL)-OH;Fmoc-L-Thr(α-D-GalNAc(Ac)3)-OH;Fmoc-L-Ser(α-D-GalNAc(Ac)3)-OH
SMILES: CC(OC[C@H]1OC(O[C@@H]([C@H](NC(OCC2C3=CC=CC=C3C3=CC=CC=C23)=O)C(=O)O)C)[C@H](NC(=O)C)[C@@H](OC(=O)C)[C@H]1OC(=O)C)=O
Formula: C33H38N2O13
M.Wt: 670.660430431366
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Fmoc-Thr[GalNAc(Ac)3-α-D]-OH i a building block in the development of cancer vaccine
In Vitro: The O-glycosidic linkage and the O-acetyl protection in this building block is stable to both piperidine and TFA, making it completely compatible with standard protocols in Fmoc solid phase peptide synthesis. The Tn antigen is a tumor-associated carbohydrate antigen that is not normally expressed in peripheral tissues or blood cells. Expression of this antigen, which is found in a majority of human carcinomas of all types, arises from a blockage in the normal O-glycosylation pathway in which glycans are extended from the common precursor GalNAcα1-O-Ser/Thr (Tn +antigen). This precursor is generated in the Golgi apparatus on newly synthesized glycoproteins by a family of polypeptide α- N-acetylgalactosaminyltransferases (ppGalNAcTs) and then extended to the common core 1 O-glycan Galβ1-3GalNAcα1-OSer/Thr (T antigen) by a single enzyme termed the T-synthase (core 1 β3-galactosyltransferase or C1GalT). Formation of the active form of the T-synthase requires a unique molecular chaperone termed Cosmc, encoded by Cosmc on the X-chromosome[1].
References: [1]. Ju T, et al. The Cosmc connection to the Tn antigen in cancer. Cancer Biomark. 2014 Jan 1;14(1):63-81.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC33635 DODAP DODAP, also known as 1,2-Dioleoyl-3-dimethylammonium-propane, is a cationic lipid. It has been used as a component in liposomes that can be used to encapsulate siRNA, immunostimulatory oligodeoxynucleotides, antisense oligonucleotides, or chemotherapeutic agents for in vitro and in vivo delivery.
DC58047 DSPE-PEG 2000 PEG2000-DSPE is used for creating micelles that are able to carry drugs with low solubility.
DC31000 LP-01 LP-01 is an ionizable cationic amino lipid (pKa = ~6.1). It has been used in the generation of lipid nanoparticles (LNPs). LNPs containing LP-01 and encapsulating both Cas9 mRNA and modified single-guide RNA (sgRNA) for the transport protein transthyretin (Ttr) induce gene editing in liver cells in mice in a dose-dependent manner resulting in reduced serum Ttr levels for at least 12 months.
DC66546 R-Sirpiglenastat R-Sirpiglenastat is the R- isomer of Sirpiglenastat(DRP-104).Sirpiglenastat (DRP104) is a broad acting glutamine antagonist. Sirpiglenastat has anticancer effects by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response.
DC60597 AZD0780 AZD0780 is the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia.
DC66114 FAPI-46 FAPI46 is a quinoline-based fibroblast activation protein (FAP)-targeted radiotracer. FAPI-46 has higher tumor uptake and prolonged tumor accumulation. FAPI 46 can be used for tumor imaging of a multitude of different cancers.
DC60580 Endosidin5(ES5) Endosidine 5 (ES5), is one of the most potent small molecules interferes with recycling endosomes through Annexin A6, thereby promoting the release and expression of mRNA into the cytoplasm. The delivered mRNAs is greatly enhanced via inhibition of endocytic recycling in cells and in live mice. NAV2729 (NAV) and endosidin 5 (ES5), resulted in significant enhancement (1.5–2 folds) of LNP-mediated delivery of Fluc mRNAs. Incubation of NAV and ES5 together caused modest further increases in Fluc expression in comparison to the sole application of either compound.
DC90056 PLX-5622 HCl form (water solubility form) PLX5622 is the HCl salt form of PLX-5622, which has better water solubility.PLX-5622 is a highly selective brain-penetrant CSF1R inhibitor (IC50=0.016 µM; Ki=5.9 nM) allowing for extended and specific microglial elimination, preceding and during pathology development.
DC60559 PT-179 PT-179 is a new orthogonal immunomodulatory drug (IMiD) derivative that binds CRBN but does not induce degradation of off-target proteins. PT-179 potently degrades proteins fused to SD40 at either the N or C terminus.
DC65841 MC1 MC1 is a selective and potent inhibitor for COX-2, and [11C]MC1 detected COX-2 in nonhuman primates after intracerebral injection of an inflammogen.
X
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Site Map|Privacy PolicyCopyright © 2018-2020 All Rights Reserved. Technical Support:KuuJia